ছবি: Photo: Collected
The pharmaceutical and chemical sector of the country’s stock market comprises 34 listed companies. Among them, 28 have published their financial reports for the October-December 2024 quarter. According to the disclosed data, 13 companies recorded an increase in earnings per share (EPS), while 8 companies reported a decline, and 7 remained in losses during this period.
The companies that saw an increase in earnings are JMI Syringes & Medical Devices Limited, Navana Pharmaceuticals Limited, Orion Infusion, Kohinoor Chemical Co. (BD) Ltd., ACME Laboratories Ltd., Beacon Pharmaceuticals PLC, Square Pharmaceuticals PLC, Beximco Pharmaceuticals Ltd., Marico, Ibn Sina Pharmaceutical Industry PLC, MB Pharmaceuticals PLC, Far Chemical Industries Ltd., and ACI Formulations Ltd.
JMI Syringes & Medical Devices Limited reported an EPS of 98 paisa for the October-December 2024 quarter, compared to 7 paisa in the same period last year, marking an increase of 91 paisa. For the first six months of the fiscal year (July-December 2024), the company recorded an EPS of 1 taka 71 paisa, up from 15 paisa in the same period last year.
Navana Pharmaceuticals Limited reported an EPS of 1 taka for the second quarter, up from 98 paisa in the corresponding period last year, reflecting an increase of 2 paisa. Over the first six months of the fiscal year, the company’s EPS reached 2 taka 25 paisa, compared to 2 taka 9 paisa in the previous year.
Orion Infusion posted an EPS of 49 paisa for the second quarter, up from 41 paisa in the same period last year, an increase of 8 paisa. The company’s six-month EPS stood at 1 taka 3 paisa, compared to 1 taka 7 paisa in the corresponding period of the previous year.
Kohinoor Chemical Co. (BD) Ltd. registered an EPS of 3 taka 85 paisa for the second quarter, compared to 3 taka 10 paisa in the same quarter last year, an increase of 75 paisa. For the six-month period, the company's diluted EPS was 6 taka 87 paisa, up from 5 taka 51 paisa last year.
ACME Laboratories Ltd. recorded an EPS of 2 taka 86 paisa in the second quarter, compared to 2 taka 67 paisa in the same quarter last year, an increase of 19 paisa. The six-month EPS rose to 6 taka 86 paisa, compared to 5 taka 2 paisa in the previous year.
Beacon Pharmaceuticals PLC posted an EPS of 1 taka 91 paisa for the second quarter, an increase from 1 taka 65 paisa in the previous year’s corresponding quarter, reflecting a growth of 26 paisa. The company’s six-month EPS reached 3 taka 47 paisa, compared to 3 taka 25 paisa in the previous year.
Square Pharmaceuticals PLC reported an EPS of 7 taka 45 paisa for the second quarter, compared to 5 taka 92 paisa in the same quarter last year, reflecting an increase of 1 taka 53 paisa. The company’s six-month EPS was 14 taka 32 paisa, up from 12 taka 69 paisa in the corresponding period last year.
Beximco Pharmaceuticals Ltd. posted an EPS of 4 taka 10 paisa for the second quarter, compared to 3 taka 21 paisa in the same period last year, showing an increase of 89 paisa. The company’s six-month EPS reached 7 taka 87 paisa, compared to 6 taka 69 paisa in the previous year.
Marico reported an EPS of 44 taka 34 paisa for the third quarter, compared to 34 taka 93 paisa in the same quarter last year, marking an increase of 9 taka 43 paisa. The company’s nine-month EPS stood at 145 taka 65 paisa, up from 114 taka 22 paisa in the corresponding period last year.
Ibn Sina Pharmaceutical Industry PLC posted an EPS of 6 taka 75 paisa for the second quarter, compared to 6 taka 70 paisa in the same quarter last year, reflecting an increase of 5 paisa. The company’s six-month EPS stood at 9 taka 47 paisa, down from 11 taka 92 paisa in the previous year.
MB Pharmaceuticals PLC recorded an EPS of 62 paisa for the second quarter, up from 60 paisa in the same quarter last year, marking an increase of 2 paisa. The company’s six-month EPS reached 1 taka 32 paisa, compared to 1 taka 20 paisa in the previous year.
Far Chemical Industries Ltd. posted an EPS of 16 paisa for the second quarter, up from 13 paisa in the corresponding period last year, marking an increase of 3 paisa. The company’s six-month EPS was 32 paisa, up from 20 paisa last year.
ACI Formulations Ltd. reported an EPS of 4 taka 40 paisa for the second quarter, compared to 2 taka 70 paisa in the same quarter last year, showing an increase of 1 taka 70 paisa. The company’s six-month EPS reached 6 taka 75 paisa, compared to 4 taka 34 paisa in the previous year.
The overall performance of the pharmaceutical and chemical sector in the stock market indicates that a significant number of companies have experienced growth in earnings, reflecting a positive trend in the industry despite economic challenges.
repoter
